Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floor J Backes

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|August 16, 2012
Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?Floor J Backes, Brent J Tierney, Eric L Eisenhauer, et al.
Gynecologic Oncology|August 13, 2017
Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based careLeigha Senter, David M O'Malley, Floor J Backes, et al.
Frontiers in Oncology|April 24, 2023
Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancerCourtney J Riedinger, Morgan Brown, Paulina J Haight, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2014
Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 studyRitu Salani, David M O'Malley, Larry J Copeland, et al.
Future Oncology (London, England)|January 17, 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancerRitu Salani, Tirza Areli Calderón Boyle, Jonathan Lim, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
American Journal of Obstetrics and Gynecology|July 15, 2011
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendationsRitu Salani, Floor J Backes, Michael Fung Kee Fung, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|August 16, 2012
Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?Floor J Backes, Brent J Tierney, Eric L Eisenhauer, et al.
Gynecologic Oncology|August 13, 2017
Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based careLeigha Senter, David M O'Malley, Floor J Backes, et al.
Frontiers in Oncology|April 24, 2023
Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancerCourtney J Riedinger, Morgan Brown, Paulina J Haight, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2014
Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 studyRitu Salani, David M O'Malley, Larry J Copeland, et al.
Future Oncology (London, England)|January 17, 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancerRitu Salani, Tirza Areli Calderón Boyle, Jonathan Lim, et al.
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|June 25, 2019
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)Floor J Backes, David Cohen, Ritu Salani, et al.
American Journal of Obstetrics and Gynecology|July 15, 2011
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendationsRitu Salani, Floor J Backes, Michael Fung Kee Fung, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Pageof 11